Hernndez-Montoliu L, Rodrguez-Pea M-M, Puig R, Astiarraga B, Guerrero-Prez F, Virgili N, Lpez-Urdiales R, Osorio J, Monseny R, Lazzara C et al (2023) A specific gut microbiota signature is associated with an enhanced GLP-1 and GLP-2 secretion and improved metabolic control in patients with type 2 diabetes after metabolic Roux-en-Y gastric bypass
As final proof of the concept, it counteracts the pathological presentation of neurodegenerative diseases in acknowledged animal models (i.e., Parkinsons disease and Alzheimers disease) and presents prominent anti-tumor potential in vivo and in vitro (Figure 4)
Br Med J 1958
Craig Koniver , it is typically injected subcutaneously (under the skin) so it can travel to the pituitary gland, where it stimulates growth hormone release into the bloodstream 1